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The IR6 protein of different plaque isolates from three passages of the equine herpesvirus 1 strain Rac was investigated.
Southern blot and DNA sequence analyses revealed that plaque isolates from the 12th passage (RacL11 and RacL22)
retained both copies of the IR6 gene, whereas two different genotypes were observed by the 185th passage: RacM24 still
harbored both copies of the IR6 gene, whereas RacM36 deleted one of the two copies. In the 256th passage (RacH), both
copies of the IR6 gene were absent. As compared to the wild-type IR6 protein, both the RacM24 and RacM36 IR6 protein
displayed amino acid exchanges at positions 34, 42, 110, and 134 of the 272 amino acid polypeptide. It is shown that (i)
the IR6 protein is nonessential for virus growth in vitro. (ii) In RacL11-infected equine and rodent cells, the typical rod-like
appearance of the IR6 protein could be detected from 6 hr p.i., whereas in RacM24- and RacM36-infected cells formation
of these structures was not observed. (iii) The RacL11 IR6 gene product was present in both the nuclei and cytoplasmic
fraction of infected cells. In contrast, the IR6 protein of both RacM24 and RacM36 colocalized with cytoplasmic membrane
vesicles. (iv) The RacL11 and RacL22 IR6 protein is present in viral nucleocapsids, whereas that of RacM24 and RacM36
is not incorporated into virions. (v) The RacL11 IR6 gene product aggregated to disulfide-linked oligomers, whereas the
RacM24 and RacM36 IR6 protein showed only marginal oligomerization. (vi) In COS7 cells transfected with constructs
expressing either the full-length RacL11-IR6 protein or a truncated form lacking the 81 carboxyterminal amino acids, the
formation of rod-like structures was observed, indicating that another viral protein is not necessary for aggregation of the
IR6 protein. In contrast, the IR6 protein expressed from constructs derived from either RacM24 or RacM36 failed to form
these structures. (vii) Analyses of chimeric RacL11-RacM24 IR6 proteins suggest a crucial role for amino acid Leu-134 in
the ability of the IR6 protein to form the rod-like structures. q 1996 Academic Press, Inc.
INTRODUCTION identified in the equine herpesvirus 4 and bovine herpes-
virus 1 genomes. In both viruses, it is present as a hap-
The equine herpesvirus type 1 (EHV-1), a member of
loid gene located in the US segment of the genomethe Alphaherpesvirinae, is responsible for mild respira-
(Nagesha et al., 1993; Leung-Tack et al., 1994). The gene
tory disease and abortions in horses; further, it is associ- product of IR6 of EHV-1 is a 31- to 33-kDa phosphoprotein
ated with neurological disorders (O’Callaghan et al., which is present in infected cells throughout the replica-
1983; Allen and Bryans, 1986). Its genome has been se- tion cycle from 1 to 2 hr p.i. In cells infected with EHV-1
quenced (Telford et al., 1992) and is composed of a strain KyA, the IR6 protein forms rod-like structures from
unique long (UL) and a short (S) region, the latter being 6 hr p.i., which seem to coalesce around the nuclei of
comprised of a unique short segment (US) bracketed by infected cells from 8 hr p.i. (O’Callaghan et al., 1994). The
two inverted repeats (IR) (Henry et al., 1981; Whalley et IR6 protein is a component of nucleocapsids but to date
al., 1981). Contained in the genome are at least 72 unique no function could be attributed to the abundantly pro-
genes and 6 diploid genes that are present in both the duced protein (O’Callaghan et al., 1994), although it has
terminal and internal IR (Harty et al., 1989; Harty and been suspected to be essential for virus growth since
O’Callaghan, 1991; Breeden et al., 1992; Holden et al., no plaque-purified IR6-negative viruses could be isolated
1992a,b,c; Telford et al., 1992). One of the diploid IR upon attempted b-gal insertion (Sun and Brown, 1994).
genes, IR6 (ORF67), has been shown to be transcribed The same authors, however, have recently reported the
to an early, abundantly produced 1.2-kb RNA (Breeden isolation of an ORF67 (IR6) deletion mutant in EHV-1
et al., 1992). Homologues of the IR6 gene have been strain Ab4 (Sun et al., 1995).
The equine herpesvirus strain Rac was isolated in Po-
land in the 1960s. After 256 serial passages in porcine1 To whom correspondence and reprint requests should be ad-
embryonic kidney cells, the progeny virus (RacH) lost itsdressed. Fax: /49-89-2180-2597. E-mail: u8a11ab@sunmail.Irz-muen-
chen.de. virulence both for laboratory animals and the natural host
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and is used as a modified live vaccine (Mayr et al., 1968). mM Tris – Cl (pH 8.0) containing 0.25 M sucrose with a
rubber policeman, and broken by 20 strokes with aAnalysis of plaque isolates from different cell culture pas-
sages (passage 12, RacL11 and RacL22; passage 185, Dounce homogenizer. Broken cells were examined by
light microscopy to ensure the efficiency of cell breakageRacM24 and RacM36; passage 256, RacH) revealed that
from the 185th passage, Rac was avirulent for both baby and to exclude nuclear damage. Nuclei, large membrane
sheets, and unbroken cells were pelleted by centrifuga-hamsters and mice (Mayr et al., 1968; Osterrieder et al.,
1994b). Restriction enzyme, PCR, and sequence analyses tion at 1,000 g for 10 min (fraction P1). Supernatants were
collected and heavy mitochondria and membrane sheetsrevealed that RacM36 and RacH had lost one or both
copies of IR6, respectively, whereas RacL11, RacL22, and were isolated by centrifugation at 3,000 g for 10 min
(fraction P2). Supernatants from this preparation wereRacM24 still retain two copies of the gene (Meyer et al.,
1992; Osterrieder et al., 1994a,b). harvested and centrifuged at 10,000 g for 20 min to purify
mitochondria, lyso- and peroxisomes, and Golgi mem-Since the loss of the IR6 gene (ORF 67) is the only
deletion of the avirulent RacH strain known to date and branes (fraction P3). The supernatant from this fraction
was centrifuged at 100,000 g for 40 min to isolate mem-both or one copies of this gene are still present in the
avirulent plaque isolates RacM24 and RacM36, respec- brane vesicles from the ER and Golgi network. The super-
natant from this fraction (S4) represents the soluble com-tively, an in-depth analysis of the IR6 gene and protein
of different Rac isolates was conducted. DNA sequence ponents of the cytoplasm. All preparations were diluted
to the same volume (3 ml), and aliquots were run onanalysis revealed that the IR6 protein of the RacM-iso-
lates harbored four amino acid substitutions as com- SDS – PAGE and analyzed by Western blotting (see
below).pared to the IR6 protein of the virulent parental RacL11.
Interestingly, the IR6 protein of the RacM-isolates lost
the capacity to form the typical rod-like structures ob- Reagents and plasmids
served in the virulent RacL11. Immunofluorescence anal-
yses of hybrid forms of the IR6 protein transiently ex- The BamHI-N fragment of RacL11 containing one copy
of the IR6 (ORF67) gene was cloned into pTZ18R (Phar-pressed from chimeric RacL11-RacM24 IR6 constructs
in COS7 cells revealed that loss of the rod-formation macia) using T4 ligase (Boehringer), and the recombinant
plasmid was designated pXu1A. This fragment was la-phenotype correlated with the substitution of Pro for Leu
at amino acid position 134 in the 272 amino acid polypep- beled by random priming with digoxigenin (Boehringer)
according to the manufacturer’s instructions and usedtide.
for Southern blot analysis. The IR6 genes of RacL11,
RacM24, and RacM36 were amplified by standard PCRMATERIALS AND METHODS
(Saiki et al., 1988) using the thermostable polymerases
Viruses and cells Taq (Boehringer) or Pfu (Stratagene), which exhibits 3*
proof reading capabilities. The PCR for the detection ofVarious plaque isolates of EHV-1 strain Rac were ex-
the IR6 genes in the different strains was performed ex-amined (RacL11, RacL22, RacM24, RacM36, and RacH).
actly as previously described (Osterrieder et al., 1994a).All strains were propagated and titrated on equine der-
For amplification of the IR6 gene, two primers were se-mal cells Edmin337 as described elsewhere (Osterrieder
lected. The 5* primer (5*-ACGTGGATCCATGAACTCC-et al., 1995). Equine fibroblast cell line NBL6, equine
GACATGATGA CAGCC-3*) contained an added BamHIteratocarcinoma cell line ETCC, and Rk13 cells were
restriction site (bold underlined) and started with the firstmaintained in EMEM containing 5% fetal calf serum (FCS)
ATG of the IR6 gene and the 3* primer (5*-ACGTTCTAGA-and infected with viruses at an m.o.i. of 1 unless other-
TTATCAAACG GCCACGGGGG-3*) contained an addedwise stated. EHV-1 strain KyA (O’Callaghan et al., 1994)
XbaI restriction site (bold underlined) and the IR6 stopwas used as a control and propagated in L-M mouse
codon. The Pfu-generated amplicon of RacL11-IR6 (850fibroblasts or Rk13 cells. Virions were purified by density bp) was cloned into the plasmid pGEX-4T-1 (Pharmacia)centrifugation through 20 to 70% sucrose gradients
and termed pGIR6L. The GST-RacL11-IR6 fusion protein(SW40 rotor, 35,000 rpm, 100 min). Nucleocapsids were
(pepGIR6L) was purified over GST-Sepharose columnspurified exactly as described by Gibson and Roizman
from 300-ml cultures as recommended by the supplier.(1972). All virus and capsid preparations were tested for
Similarly, pGDIR6L was constructed by inserting a Taq-purity by electron microscopy.
generated PCR amplicon into this vector. Nucleotide se-
quencing revealed that pGDIR6L contained an 81 aminoCellular fractionation
acid carboxy-terminally truncated version of RacL11-IR6.
The overexpressed fusion protein was also purified andSubcellular fractions were prepared by differential cen-
trifugation as described elsewhere (Graham, 1984). termed pepGDIR6L. The respective amplicons were fur-
ther cloned into eucaryotic expression vectors under theBriefly, 1 1 107 ETCC cells infected with the various Rac-
passages were harvested at 12 hr p.i., scraped into 5 control of either the SV40 early promoter (pSV-Sport,
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Gibco-BRL), resulting in recombinant plasmids pSVIR6L Antibodies against dynein, kinesin, and desmin were
used according to the supplier’s (Sigma) recommenda-and pSVDIR6L, respectively, or under control of the CMV
immediate early promoter (pcDNAI/Amp, Invitrogen) and tions.
plasmids were termed pDIR6L and pDDIR6L. Pfu-gener-
ated amplicons of RacM24- and RacM36-IR6 were Transient expression of various IR6 proteins
in COS7 cellscloned into pcDNAI/Amp and were termed pDIR6M24
and pDIR6M36, respectively. Plasmid pSVIR6 (KyA) has
COS7 cells were transfected with the Lipofectin reagentbeen previously described (O’Callaghan et al., 1994), and
or by electroporation as described in detail elsewherethe insert was also subcloned into pcDNAI/Amp resulting
(O’Callaghan et al., 1994; Osterrieder et al., 1995). The re-in plasmid pDIR6KyA. Nucleotide sequencing was per-
combinant plasmids used were pSVIR6L, pSVIR6KyA,formed by the dideoxy chain termination cycle sequenc-
pSVDIR6L, pDIR6L, pDIR6KyA, pDDIR6L, pDIR6M24, oring method using an automatic sequencer (ABI) and Sp6
pDIR6M36. Cells were harvested at different time pointsand T7 primers.
after transfection and analyzed by Western blotting or indi-
rect IF.Purification of viral DNA and Southern blotting
EHV-1 virion proteins were hydrolyzed by incubation RESULTS
with Proteinase K (10 mg/ml) for 3 hr at 567 and extracted
with phenol and chloroform. Viral DNA was precipitated Southern blot analysis of Rac-passages
from the aqueous phase using 4 M LiCl and ethanol,
The various Rac-isolates were propagated to virus ti-cleaved with BamHI and separated on 0.8% agarose gels.
ters of 1 1 106 PFU/ml in equine and rabbit kidney cellsDNA fragments were transferred to positively charged
as described under Materials and Methods. Viral DNAnylon membranes (HybondN/, Amersham) by vacuum
was isolated from partially purified RacL11, RacL22,blotting using 0.4 M NaOH (Reed and Mann, 1985).
RacM24, RacM36, and RacH virions, cleaved with BamHI,Sheets were incubated with heat-denatured pXu1A sus-
and separated in 0.8% agarose gels. Southern blot hy-pended in hybridization solution (Sambrook et al., 1989).
bridization with labeled pXu1A as a probe revealed thatDetection of hybrids with an antidigoxigenin AP conju-
fragments of 4.9 kbp (BamHI-N) and 4.5 kbp (BamHI-P)gate was performed according to the manufacturer’s in-
reacted with the probe in Rac plaque-isolates RacL11,structions (Boehringer).
RacL22, and RacM24. In the case of the RacM36, the
probe detected a 4.9-kbp fragment and a shortenedSDS –polyacrylamide gel electrophoresis (PAGE),
BamHI-P fragment (3.6 kbp). In DNA of RacH, fragmentsnative PAGE and Western blotting
of only 4.0 and 3.6 kbp were reactive with that probe
For SDS –PAGE, purified virions, viral nucleocapsids, (Fig. 1A). The doublet appearance of the bands resulted
or infected-/mock-infected cell lysates were heated to from the variability within reiterated sequence motifs in
957 in sample buffer (Sambrook et al., 1989) and sepa- the noncoding region downstream of the IR5 gene (P. H.
rated on 5– 10% denaturing polyacrylamide gels (Laem- Hu¨bert and N. Osterrieder, unpublished data; Breeden
mli, 1970). Nondenaturing PAGE (5– 10%) was performed et al., 1992; Telford et al., 1992). Supernatant viruses of
exactly as described by Cohen et al. (1986). Separated Rk13 cells infected with the different EHV-1 strains were
proteins were transferred to nitrocellulose by the semidry also analyzed by PCR for the presence or absence of the
method (Kyhse-Andersen, 1984). IR6 was detected by a IR6 gene. This PCR protocol is capable of distinguishing
monospecific antiserum (O’Callaghan et al., 1994) fol- between an intact IR6 gene (495 bp) and the RacM36-
lowed by detection with anti-rabbit IgG alkaline phospha- and RacH-specific deletions within the IR6 gene, yielding
tase conjugate. Color reaction was achieved with NBT/ amplicons of only 310 bp (Osterrieder et al., 1994a). As
X-phosphate. expected, a 495-bp band could be demonstrated in su-
pernatants of cells infected with KyA, RacL11, RacL22,
Indirect immunofluorescence
and RacM24. In supernatants of RacM36-infected cells,
both a 495- and a 310-bp band were detected. Only theIndirect immunofluorescence analyses of Rac-infected
cells or cells transfected with various plasmids were smaller band was detected in RacH supernatants. These
results were in agreement with those of the Southerndone as described previously (O’Callaghan et al., 1994).
Briefly, cells were fixed with ice-cold acetone for 5 min blot analysis and confirmed the presence of two copies
(KyA, RacL11, RacL22, RacM24), one copy (RacM36), andat different times p.i. or after transfection, dried, and rehy-
drated with PBS. After blocking with 10% normal goat no copies (RacH) of the IR6 gene in the respective geno-
types of the investigated EHV-1 strains (Osterrieder etserum in PBS, slides were incubated with an 1:2000 dilu-
tion of anti-IR6 antiserum in PBS. Slides were washed al., 1994a,b). The genomic organization of the IR regions
of the respective Rac plaque-isolates is shown in Fig.and incubated with anti-rabbit IgG FITC or Rhodamin
conjugate and examined by fluorescence microscopy. 1B. The above findings and the observation that the RacH
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obvious (Figs. 2B and 2C). In cells infected with RacM24
or RacM36, therefore, no rod-formation was observed in
any cell type at any time p.i., although large amounts of
the IR6 protein were produced as estimated from the
signal intensities. No IR6 protein was detectable in any
of the cell lines after infection with RacH or mock infec-
tion (Fig. 2D).
Western blot analyses of the IR6 protein of RacL11,
RacM24, RacM36, and RacH and of bacterial
IR6-GST-fusion proteins
Lysates of infected ETCC, Edmin337, and Rk13 cells
were analyzed by Western blotting under denaturing and
nondenaturing conditions. In all these cell lines, the 31-
kDa and the phosphorylated 33-kDa IR6 protein species
were detectable in denaturing PAGE from 2 to 12 hr after
infection with RacL11, RacM24, or RacM36. In RacH- and
mock-infected cell lysates, no IR6 protein was detected,
and in the case of KyA, the IR6 protein was only present
in infected Rk13 cells. In RacM24- and RacM36-infected
cells, mainly the 33-kDa species was detected (Fig. 3A).
When infected cell lysates were separated under nonde-
naturing conditions, formation of IR6 dimers, tetramers,
hexamers, and octamers was readily detected in RacL11-
FIG. 1. (A) Southern blot analysis of different Rac plaque-isolates and KyA-infected cell lysates (Fig. 3B). The finding that
using the labeled BamHI-N fragment of plasmid pXu1A as a probe. In the IR6 protein complexes were not detected in the
RacL11 and RacL22 (passage 12) and RacM24 (passage 185) both the RacL11- and KyA-infected cell lysates in the presence of
4.9-kbp BamHI-N and the 4.5-kbp BamHI-P fragment were detected. In
2-mercaptoethanol (Fig. 3A) indicated that disulfideRacM36 (passage 185), the 4.9-kbp BamHI-N and a shortened (3.6 kbp)
bonds play an important role in IR6 protein oligomeriza-BamHI-P fragment were detected. In RacH (passage 256), fragments of
approximately 4.0 and 3.6 kbp were detected. The sizes of the reactive tion. In contrast, the formation of IR6 oligomers was virtu-
fragments are indicated. (B) Genomic organization of the Rac plaque- ally absent in RacM24- and RacM36-infected cell lysates
isolates. The inverted repeat and US regions of RacL11, RacL22, under nondenaturing conditions. In several experiments
RacM24, RacM36, and RacH and the deletions (n) present in RacM36
with the medium Rac passages, bands smaller than 31and RacH are shown.
kDa specifically reacted with the IR6 antiserum, sug-
gesting a reduced stability of the IR6 protein in these
cells.virus propagated to high virus titers demonstrated that
GST-fusion proteins harboring either the full-length IR6the IR6 gene is not essential for EHV-1 replication in
protein (pepGIR6L) or a carboxy-terminally truncated IR6vitro.
protein (pepGDIR6L) of RacL11 were analyzed under de-
Immunofluorescence analyses naturing and nondenaturing conditions by native PAGE.
Sequencing of pGDIR6L revealed that it contained only
In order to examine the phenotypes of the IR6 proteins, part of the IR6 ORF and would encode an IR6 protein
Edmin337, ETCC, NBL6, or Rk13 cells seeded on glass that lacked the carboxy-terminal 81 amino acids (Fig. 7).
slides were infected with RacL11, RacM24, RacM36,
However, both proteins were shown to form the already
RacH, or KyA. At 6, 8, 10, 12, and 24 hr p.i., cells were fixed
described oligomers in the absence of 2-mercaptoetha-
and analyzed by indirect immunofluorescence using a
nol, indicating that the carboxy-terminal 81 amino acids
monospecific IR6 antiserum. In all cell types infected with
of the IR6 polypeptide are not required for its ability to
RacL11 and in Rk13 cells infected with KyA, IR6-specific form disulfide-linked complexes (Fig. 3C).
rod-like structures were detectable from 6 hr p.i. The
rods could be demonstrated until 24 hr p.i. as examplarily Subcellular location of the IR6 protein
shown for RacL11-infected ETCC cells fixed at 10 hr p.i.
(Fig. 2A). In contrast, an even distribution of the IR6 pro- To address the location of the IR6 protein in infected
cells, subcellular fractions prepared at 12 hr p.i. weretein throughout the cytoplasm was observed in all cell
types infected with either RacM24 or RacM36. This distri- analyzed by Western blotting. The IR6 protein localized
to the nuclear fraction (P1) and the soluble fraction (S4)bution was also visible at 10 and 24 hr p.i. when a more
granular appearance of the IR6 gene product became of the cytoplasm of RacL11-infected cells (Fig. 4). A faint
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reaction was obtained in the 100,000 g pellet fraction protein in rod-formation, plasmids containing the IR6
gene of different strains and a truncated RacL11 IR6(P4) which could be due to pelleted virions. In contrast,
the IR6 protein of RacM24 also localized to the nuclear sequence under the control of the CMV immediate early
promoter or the SV40 early promoter were transfectedfraction (P1) but was not detected in the soluble fraction
of the cytoplasm (S4). Rather, it was associated with into COS7 cells. Transfected cells were subsequently
analyzed by Western blotting and indirect IF at 48, 72,microsomal and lyso-/peroxisomal fractions of infected
cells (P2 and P3; Fig. 4). The reduced stability of the IR6 and 96 hr posttransfection. Expression of IR6 in COS7
cells was detectable at all time points by immunoblotgene product in RacM24-infected cells was confirmed in
this experiment since multiple bands were observed. As analysis of cell lysates with the anti-IR6 antiserum. The
RacM24 and RacM36 IR6 protein again showed a de-expected, no reaction of the antiserum was seen in frac-
tions from cells infected with RacH or from mock-infected creased stability upon transfection (data not shown). Indi-
rect IF analyses revealed that expression of the RacL11cells.
and KyA IR6 genes led to the formation of rods from 48
Incorporation of the IR6 protein into viral hr posttransfection of pDIR6L/pSVIR6L and pDIR6KyA/
nucleocapsids pSVIR6KyA, respectively (Fig. 6A and Table 1). These
rods were also detectable at 72 and 96 hr after transfec-Previous studies have shown that the IR6 protein is
tion of pDDIR6L/pSVDIR6L (Fig. 6C), indicating that thea component of the nucleocapsid in EHV-1 strain KyA
last 81 amino acids of the IR6 protein are not involved(O’Callaghan et al., 1994) and is present in the nonenve-
in its ability to form the aggregate structures. However,lope fraction of purified virions of the EHV-1 Ab4 strain
rod-formation was less pronounced in these cells and(Sun et al., 1995). To investigate the incorporation of the
appeared to occur mainly within nuclei of transfectedIR6 protein in virions of the different Rac-passages, viri-
cells. In contrast, in cells transfected with pDIR6M24 orons and nucleocapsids were purified and analyzed by
pDIR6M36, no formation of IR6-specific rods was detect-Western blotting. RacL11 and RacL22 virions were shown
able and the distribution of the IR6 protein closely resem-to have incorporated the IR6 protein, whereas purified
bled that observed after infection with the respective vi-virions of RacM24 and RacM36 did not (Fig. 5). Further,
ruses (Fig. 6B). These findings indicated that (i) rod-for-the presence of the IR6 protein in nucleocapsids of
mation in wt IR6-expressing cells is not dependent onRacL11 and RacL22 was confirmed (Fig. 5). RacM24 and
any other EHV-1 protein and (ii) that the inability of theRacM36 nucleocapsids did not contain the IR6 gene
IR6 protein of RacM24 and RacM36 to aggregate is notproduct, although the protein was shown to localize to
due to interaction of the IR6 protein with another EHV-1the nuclei of infected cells. The same preparations were
protein which would inhibit rod-formation. In addition,also analyzed by Western blotting with anti-glycoprotein
colocalization studies with antibodies to cellular proteinsgB mab 4B6 (Osterrieder et al., 1995) as a control. As
did not reveal an association of the IR6 gene productexpected, there was a reaction with the gB present in
with desmin, kynein, or dynein (data not shown).purified RacL11, RacL22, RacM24, RacM36, and RacH
virions, and no reaction was observed with preparations
Sequence analysis of RacL11, RacM24, andof viral nucleocapsids. Taken together, these findings
RacM36 IR6revealed that the RacM24 and the RacM36 IR6 gene
product behaves differently compared to the wt IR6 pro- From the above described experiments, it was appar-
tein (RacL11 and KyA) concerning oligomerization, rod- ent that only alterations in the IR6 amino acid sequences
formation, subcellular location, stability in infected cells, of RacM24 and RacM36 could be responsible for the
and incorporation into nucleocapsids. different behavior of the IR6 proteins encoded by these
plaque isolates compared to the wt IR6 gene product.
Phenotype of the IR6 proteins after transient
Therefore, the nucleotide sequences and predicted
expression of IR6 genes of various EHV-1 strains
amino acid sequences of IR6 in RacM24, RacM36, and
the carboxy-terminally truncated version of IR6 were de-To address the question of the possible requirement
for another EHV-1 protein(s) to associate with the IR6 termined and compared to those of wt IR6 (KyA and
FIG. 2. Distribution of the IR6 protein in equine ETCC cells infected with the different plaque isolates of EHV-1 Rac at 10 hr p.i. Whereas intensive
rod formation was detectable in cells infected with RacL11 (A), no rods were visible in RacM24- (B), or RacM36-infected cells (C). An even to
granular appearance of the IR6 protein in the cytoplasm of cells was observed. In RacH- (D) or mock-infected cells, no signal was obtained after
indirect immunofluorescent staining with anti-IR6 antiserum.
FIG. 6. Transient expression of IR6 of the different Rac plaque isolates in COS7 cells after transfection (see Materials and Methods). (A) Rod
formation was detected at all times (48, 72, and 96 hr) after transfection with pDIR6L. (B) An even to granular distribution of IR6 was observed after
transfection of pDM24IR6 or pDIR6M36 (see Table 1). (C) Transfection of pDDIR6L resulted in an even distribution of the IR6 protein with the
appearance of rods at 72 and 96 hr after transfection. (D) No staining was obtained after transfection with pcDNAI/Amp. Transfections with the
respective IR6 genes under the SV40 early promoter gave identical results (see Table 1).
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FIG. 3. Western blot analysis of IR6 proteins with monospecific anti-IR6 antiserum in infected Rk13 and ETCC cell lysates under denaturing (A)
and native (B) conditions at 12 hr p.i. and Western blot analysis of IR6-GST-fusion proteins (C). (A) The different plaque isolates of EHV-1 Rac and
KyA were separated in 10% polyacrylamide gels, blotted, and incubated with the anti-IR6 antiserum. The respective isolates and the molecular
weights (in kDa) of the IR6 protein are indicated. (B) The same samples were also separated by nondenaturing PAGE (10%), blotted, and incubated
with the anti-IR6 antiserum to demonstrate oligomerization of the IR6 protein. Molecular weights (in kDa) are indicated on the left. (C) Both the full-
length GST-IR6-fusion protein (pepGIR6L) and the truncated GST-IR6-fusion protein (pepGDIR6L) were separated by nondenaturing PAGE (5%) in
the absence (0) or presence (/) of 2-mercaptoethanol. Molecular weights (in kDa) are indicated on the left.
RacL11). As demonstrated in Fig. 7, there were a total of spectively. The Chou-Fasman algorithm (Chou and Fas-
man, 1978) would predict that these substitutions causefour amino acid changes in the IR6 amino acid se-
quences of both RacM24 and RacM36 when compared the disruption of a b-sheet structure present in the wt
IR6 polypeptide and generate ab-turn. A similar potentialto wt IR6. One or more of these changes could be respon-
sible for the inability of RacM24 and RacM36 IR6 gene alteration in the structure of the IR6 protein may result
from the change of a Leu to Pro at position 134. Ac-product to form either IR6 protein oligomers and/or the
typical rod-like structures as well as for the lack of incor-
poration of the IR6 gene product into nucleocapsids. Ala-
nine residues at positions 34 and 42 in the wild-type
protein (RacL11, KyA) were changed to Asp and Val, re-
FIG. 4. Subcellular fractionation of infected ETCC cells (12 hr p.i.)
and Western blot analysis using the anti-IR6 antiserum. Whereas the
RacL11 IR6 protein is mainly contained within the soluble fraction of FIG. 5. Analysis of purified virions and viral nucleocapsids by West-
ern blotting with the anti-IR6 antiserum (top panel). The IR6 proteinthe cytoplasm (fraction S4) and the nuclei (fraction P1), the RacM24
IR6 protein partitions with membranaceous vesicles (fractions P2 and was detected in nucleocapsids of RacL11 and RacL22 but was not
present in RacM24, RacM36, or RacH virions or nucleocapsids. As aP3) and the nuclei (fraction P1). A small amount of the IR6 protein
was detected in fraction P4 of RacL11-infected cells. No reaction was control, the same preparations were analyzed by Western blotting using
the anti-EHV-1 gB monoclonal antibody 4B6 (bottom panel).obtained with RacH- or mock-infected subcellular fractions.
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TABLE 1
Rod-Formation upon Transient Expression of IR6 in COS7 Cells with Different Constructs
IR6 distribution in the cytoplasm of transfected COS7 cells
Plasmida 48 hr b 72 hr 96 hr
pDIR6L11/pSVIR6L11 Rods Rods Rods
pDDIR6L11/pSVDIR6L11 Even/rods Rods Rods
pDIR6M24 Evenc Even/granular Even/granular
pDIR6M36 Even Even/granular Even/granular
pDIR6KyA/pSVIR6KyA Rods Rods Rods
pcDNAI/Amp Noned None None
a 10 mg of plasmid DNA were transfected into cells by either electroporation or using the Lipofectin reagent. An influence of the transfection
method on the IR6 distribution in cells could not be found.
b The time points indicate when cells were fixed after transfections.
c The IR6 protein in transfected cells did not aggregate to filamentous structures but was detectable within the cytoplasm (see Fig. 6).
d No rod formation or nonspecific staining of the cells was observed after transfection of pcDNAI/Amp.
cording to the Chou-Fasman prediction, the fourth responding to amino acids 34 to 42 and amino acid 134,
were suspected to be responsible for the different behav-change (Val to Leu at position 110) would have no signifi-
cant influence on the secondary structure of the IR6 pro- ior of the RacM24 and RacM36 IR6 protein.
teins. As a consequence, two regions of the protein, cor-
Construction of chimeric IR6 genes and analysis of
the protein phenotype after transient transfection
To map the region responsible for the failure of the
RacM24 and RacM36 IR6 proteins to form the rod-like
structures, four chimeric IR6 genes were constructed.
Using the SphI site within the IR6 gene and the PCR-
generated BamHI and XbaI sites, the amino- and car-
boxyterminal portions of the IR6 genes were exchanged
between RacL11 IR6 and RacM24 IR6. Using pDIR6L as
the original construct, pDIR6Mu1 (pDIR6L containing the
aminoterminal 68 amino acids of pDIR6M24) and
pDIR6Mu2 (pDIR6L containing the carboxyterminal 204
amino acids of pDIR6M24) were generated. Using
pDIR6M24 as the backbone, pDIR6Mu3 and pDIR6Mu4
were constructed by replacing the sequences coding for
the carboxyterminal 204 or the aminoterminal 68 amino
acids with corresponding sequences of pDIR6L, respec-
tively (Fig. 8). The chimeric constructs were transfected
into COS7 cells by electroporation and analyzed by indi-
rect IF at 48, 72, and 96 hr after transfection. At all time
points, expression of the mutant constructs encoding the
carboxyterminus of the RacL11 IR6 protein (pDIR6Mu1
and pDIR6Mu3) resulted in the formation of the IR6 rod-
like structures. In contrast, the mutants encoding the
carboxy-terminus of RacM24 IR6 (pDIR6Mu2 and
pDIR6Mu4) behaved like the parental pDIR6M24 as it
failed to generate the rod-like structures and led to an
even to granular appearance of the IR6 protein. These
observations indicated that the Val to Leu change at
FIG. 7. Comparison of the IR6 amino acid sequences of different position 110 and/or the Leu to Pro change at position
Rac plaque-isolates and the carboxy-terminal deletion mutant as de-
134 are responsible for the failure of RacM24 andscribed in the Results. Alterations in the amino acid sequences are
RacM36 IR6 to establish the wt appearance of the IR6printed in bold, and those amino acid changes affecting the secondary
structure as determined by the Chou-Fasman algorithm are underlined. protein in infected or transfected cells.
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tained within the nuclei of cells infected with RacL11,
RacM24, and RacM36. Despite this, the IR6 gene product
is incorporated only into RacL11 and RacL22 nucleocap-
sids and is not detectable in RacM24 or RacM36 nucleo-
capsids or virions. The findings that the IR6 protein is
present very early in infection, is produced in significant
quantities throughout infection, and is associated with
virions (Breeden et al., 1992; O’Callaghan et al., 1994)
suggest it may play an important role in EHV-1 infection.
This possibility is supported by the fact that RacM24,
RacM36, and RacH are avirulent for laboratory animals
as well as the natural host (Mayr et al., 1968) and that
the modification or deletion of IR6 is the only alteration
FIG. 8. Schematic illustration of the IR6 genes of RacL11, RacM24, identified to date in the genome of the attenuated Rac
and four chimeric RacL11-RacM24 constructs. The staining pattern of isolates (Osterrieder et al., 1994b, 1995). Thus, anthe respective proteins as determined by indirect IF upon transient
involvement of IR6 in EHV-1 pathogenicity cannot be ex-transfections in COS7 cells are given. Open bars represent RacL11 IR6
cluded, and the possible involvement of the IR6 proteinsequences; shaded bars represent RacM24 IR6 sequences. Restriction
sites used for the exchange of amino- and carboxyterminal portions in pathogenicity is currently being addressed by the res-
are indicated: B, BamHI; Sp, SphI; Xb, XbaI. toration of wt IR6 in RacH and subsequent animal experi-
ments.
Other differences between the wt IR6 protein and thatDISCUSSION
of RacM24 and RacM36 are the failure of the latter to
form disulfide-bonded oligomers and its increased deg-This study addressed the analysis of the IR6 protein
in plaque-isolates from different cell culture passages of radation in infected cells. This phenomenon could be
due to a transportation deficiency of the IR6 protein inthe EHV-1 strain Rac. Mutations affecting the IR6 gene
occurred during the attenuation of Rac by serial passage these strains and a subsequent enzymatic degradation
which is consistent with its localization to the lyso- andof the virus in porcine embryonic kidney cells (Mayr et
al., 1968) and finally led to the loss of the IR6 open read- peroxisomal fractions of infected cells. All described dif-
ferences in the phenotypes of the IR6 protein of wt vsing frame in RacH (Osterrieder et al., 1994a,b). Thus,
this system provides EHV-1 isolates to investigate the RacM24 or RacM36 are due to the changes in their amino
acid sequences of IR6 reported here. The failure of theinfluence of major and minor changes within the IR6
gene on the localization and behavior of the novel IR6 IR6 protein to form the rod-like structures was mapped
to substitutions in amino acid 110 and/or 134. The latterprotein and to conduct future experiments on its role in
EHV-1 pathogenesis in animal models. change from a Leu residue in wt strains to a Pro residue
in the mutated proteins has a predicted pronounced influ-Several differences in the IR6 protein were observed
when the medium passage isolates RacM24 and ence on the protein’s secondary structure and is sus-
pected to be the mutation responsible for the alteredRacM36 were compared to wt RacL11 and RacL22. In
contrast to the wild-type protein, the IR6 protein of both phenotype. Importantly, the carboxyterminal 81 amino
acids, residues 192– 272, are not responsible for the phe-RacM24 and RacM36 does not aggregate to the de-
scribed rod-like structures in the cytoplasm of infected notype of the IR6 protein described in this study since
the truncated IR6-GST-fusion protein and the transientlycells (O’Callaghan et al., 1994), but exhibits an even to
granular distribution within infected cells. This failure to expressed truncated IR6 have the capacity to oligomerize
and to form rods. These results are in good agreementform the rod-like structures may be related to an impaired
transport of the protein from the ER or Golgi network into with predictions of the amino acid sequences according
to which all regions involved in disulfide-bonding andthe cytoplasm as suggested by the different localization
of the protein when compared to that of RacL11. The phosphorylation are located in the aminoterminal portion
of the IR6 protein (Breeden et al., 1992; O’Callaghan etlocalization of the RacL11 IR6 protein in the soluble frac-
tion of the cytoplasm is in contradiction to the observa- al., 1994).
The function of the IR6 protein remains enigmatic al-tions of Sun et al. (1995) who found that the ORF 67
protein (IR6) of EHV-1 Ab4 was associated with mem- though an association with the filamentous network of
the cytoplasm is suggested by the appearance of thebranes of infected cells. A possible explanation for these
differing results could be that these authors collected protein in infected cells. To date, however, no such asso-
ciation of IR6 with filamentous structures of the cyto-the membranes by centrifugation at 50,000 g, which
could pellet virions from infected cells as shown by our plasm such as actin, tubulin, or vimentin has been shown
(O’Callaghan et al., 1994). Likewise, the colocalization offinding that small amounts of the IR6 protein are present
in fraction P4 (Fig. 4). The IR6 polypeptide is also con- the IR6 protein with the cellular proteins desmin, dynein,
AID VY 7772 / 6a11$$$663 02-23-96 13:58:08 vira AP: Virology
451MODIFICATION OF THE IR6 PROTEIN IN EHV-1
regulated by sequences within the intron of the immediate-earlyand kinesin could not be demonstrated. That the IR6
gene. DNA Sequence 3, 143– 152.protein is aggregating to the observed structures solely
Kyhse-Andersen, J. (1984). Electroblotting of multiple gels: A simple
by IR6 protein to IR6 protein interactions is possible, apparatus without buffer tank for rapid transfer of proteins from poly-
although preliminary studies of bacterial IR6 fusion pro- acrylamide to nitrocellulose. J. Biochem. Biophys. Methods 10, 203–
214.teins examined by immunoelectron microscopy do not
Laemmli, U. K. (1970). Cleavage of structural proteins during the assem-support this hypothesis (N. Osterrieder et al., unpub-
bly of the head of bacteriophage T4. Nature (London) 227, 680–685.lished observations). Hopefully, studies in progress will
Leung-Tack, P., Audonnet, J. C., and Riviere, M. (1994). The complete
give more insight into the role of this interesting protein DNA sequence and the genome organization of the short unique
in the replication and biology of EHV-1. region (US) of the bovine herpesvirus type 1 (ST strain). Virology 199,
409–421.
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